JP2003500466A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003500466A5 JP2003500466A5 JP2000621326A JP2000621326A JP2003500466A5 JP 2003500466 A5 JP2003500466 A5 JP 2003500466A5 JP 2000621326 A JP2000621326 A JP 2000621326A JP 2000621326 A JP2000621326 A JP 2000621326A JP 2003500466 A5 JP2003500466 A5 JP 2003500466A5
- Authority
- JP
- Japan
- Prior art keywords
- aminomethyl
- indan
- acetic acid
- compound
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 description 16
- 238000000034 method Methods 0.000 description 10
- 241000124008 Mammalia Species 0.000 description 9
- 229910052739 hydrogen Inorganic materials 0.000 description 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 6
- 239000001257 hydrogen Substances 0.000 description 5
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 5
- 125000004093 cyano group Chemical group *C#N 0.000 description 4
- 125000001424 substituent group Chemical group 0.000 description 4
- 229910052794 bromium Inorganic materials 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- 229940002612 prodrug Drugs 0.000 description 3
- 239000000651 prodrug Substances 0.000 description 3
- QCXMLTOWLPGLGT-UHFFFAOYSA-N 2-(aminomethyl)-2-(carboxymethyl)-1,3-dihydroindene-4-carboxylic acid Chemical compound C1=CC(C(O)=O)=C2CC(CN)(CC(O)=O)CC2=C1 QCXMLTOWLPGLGT-UHFFFAOYSA-N 0.000 description 2
- BHNNPATUPSXNSA-UHFFFAOYSA-N 2-(aminomethyl)-2-(carboxymethyl)-1,3-dihydroindene-5-carboxylic acid Chemical compound C1=C(C(O)=O)C=C2CC(CN)(CC(O)=O)CC2=C1 BHNNPATUPSXNSA-UHFFFAOYSA-N 0.000 description 2
- UXCNMSNACVGRFX-UHFFFAOYSA-N 2-[2-(aminomethyl)-1,3-dihydrocyclopenta[a]naphthalen-2-yl]acetic acid Chemical compound C1=CC=CC2=C(CC(CN)(CC(O)=O)C3)C3=CC=C21 UXCNMSNACVGRFX-UHFFFAOYSA-N 0.000 description 2
- RSBRZIIGOOVJFX-UHFFFAOYSA-N 2-[2-(aminomethyl)-1,3-dihydrocyclopenta[b]naphthalen-2-yl]acetic acid Chemical compound C1=CC=C2C=C(CC(CN)(CC(O)=O)C3)C3=CC2=C1 RSBRZIIGOOVJFX-UHFFFAOYSA-N 0.000 description 2
- XLHRVJITHVCLJF-UHFFFAOYSA-N 2-[2-(aminomethyl)-1,3-dihydroinden-2-yl]acetic acid Chemical compound C1=CC=C2CC(CN)(CC(O)=O)CC2=C1 XLHRVJITHVCLJF-UHFFFAOYSA-N 0.000 description 2
- MIQDZWUURXHFFF-UHFFFAOYSA-N 2-[2-(aminomethyl)-4,5-diphenyl-1,3-dihydroinden-2-yl]acetic acid Chemical compound C=1C=CC=CC=1C1=C2CC(CN)(CC(O)=O)CC2=CC=C1C1=CC=CC=C1 MIQDZWUURXHFFF-UHFFFAOYSA-N 0.000 description 2
- VSFJDROWPIPZAG-UHFFFAOYSA-N 2-[2-(aminomethyl)-4,7-bis(trifluoromethyl)-1,3-dihydroinden-2-yl]acetic acid Chemical compound FC(F)(F)C1=CC=C(C(F)(F)F)C2=C1CC(CN)(CC(O)=O)C2 VSFJDROWPIPZAG-UHFFFAOYSA-N 0.000 description 2
- VFMHWFDTLWSLQG-UHFFFAOYSA-N 2-[2-(aminomethyl)-4,7-di(propan-2-yl)-1,3-dihydroinden-2-yl]acetic acid Chemical compound CC(C)C1=CC=C(C(C)C)C2=C1CC(CN)(CC(O)=O)C2 VFMHWFDTLWSLQG-UHFFFAOYSA-N 0.000 description 2
- QSEFYODGNGUBHW-UHFFFAOYSA-N 2-[2-(aminomethyl)-4,7-dibromo-1,3-dihydroinden-2-yl]acetic acid Chemical compound BrC1=CC=C(Br)C2=C1CC(CN)(CC(O)=O)C2 QSEFYODGNGUBHW-UHFFFAOYSA-N 0.000 description 2
- PSHXYMCXRQKIAB-UHFFFAOYSA-N 2-[2-(aminomethyl)-4,7-dichloro-1,3-dihydroinden-2-yl]acetic acid Chemical compound ClC1=CC=C(Cl)C2=C1CC(CN)(CC(O)=O)C2 PSHXYMCXRQKIAB-UHFFFAOYSA-N 0.000 description 2
- UVHHQJTXTRGROQ-UHFFFAOYSA-N 2-[2-(aminomethyl)-4,7-dimethoxy-1,3-dihydroinden-2-yl]acetic acid Chemical compound COC1=CC=C(OC)C2=C1CC(CN)(CC(O)=O)C2 UVHHQJTXTRGROQ-UHFFFAOYSA-N 0.000 description 2
- YRTQJSSCCCCWKO-UHFFFAOYSA-N 2-[2-(aminomethyl)-4,7-dimethyl-1,3-dihydroinden-2-yl]acetic acid Chemical compound CC1=CC=C(C)C2=C1CC(CN)(CC(O)=O)C2 YRTQJSSCCCCWKO-UHFFFAOYSA-N 0.000 description 2
- OHXKEDNGJJTYDK-UHFFFAOYSA-N 2-[2-(aminomethyl)-4,7-diphenyl-1,3-dihydroinden-2-yl]acetic acid Chemical compound C1C(CN)(CC(O)=O)CC2=C1C(C=1C=CC=CC=1)=CC=C2C1=CC=CC=C1 OHXKEDNGJJTYDK-UHFFFAOYSA-N 0.000 description 2
- HHHGGJXZGPBCBI-UHFFFAOYSA-N 2-[2-(aminomethyl)-4-(2-methylpropyl)-1,3-dihydroinden-2-yl]acetic acid Chemical compound CC(C)CC1=CC=CC2=C1CC(CN)(CC(O)=O)C2 HHHGGJXZGPBCBI-UHFFFAOYSA-N 0.000 description 2
- ZGZXBFQTIXGCCM-UHFFFAOYSA-N 2-[2-(aminomethyl)-4-(dimethylamino)-1,3-dihydroinden-2-yl]acetic acid Chemical compound CN(C)C1=CC=CC2=C1CC(CN)(CC(O)=O)C2 ZGZXBFQTIXGCCM-UHFFFAOYSA-N 0.000 description 2
- ALVMUTGCMBSVHL-UHFFFAOYSA-N 2-[2-(aminomethyl)-4-(methylamino)-1,3-dihydroinden-2-yl]acetic acid Chemical compound CNC1=CC=CC2=C1CC(CN)(CC(O)=O)C2 ALVMUTGCMBSVHL-UHFFFAOYSA-N 0.000 description 2
- ZWWKDQZNDVWZPE-UHFFFAOYSA-N 2-[2-(aminomethyl)-4-(trifluoromethyl)-1,3-dihydroinden-2-yl]acetic acid Chemical compound C1=CC(C(F)(F)F)=C2CC(CN)(CC(O)=O)CC2=C1 ZWWKDQZNDVWZPE-UHFFFAOYSA-N 0.000 description 2
- DXKTVPJGEJGNDZ-UHFFFAOYSA-N 2-[2-(aminomethyl)-4-bromo-1,3-dihydroinden-2-yl]acetic acid Chemical compound C1=CC(Br)=C2CC(CN)(CC(O)=O)CC2=C1 DXKTVPJGEJGNDZ-UHFFFAOYSA-N 0.000 description 2
- OJOZXHYPHMBHEE-UHFFFAOYSA-N 2-[2-(aminomethyl)-4-chloro-1,3-dihydroinden-2-yl]acetic acid Chemical compound C1=CC(Cl)=C2CC(CN)(CC(O)=O)CC2=C1 OJOZXHYPHMBHEE-UHFFFAOYSA-N 0.000 description 2
- MLSOKLXJRHKHGL-UHFFFAOYSA-N 2-[2-(aminomethyl)-4-cyano-1,3-dihydroinden-2-yl]acetic acid Chemical compound C1=CC(C#N)=C2CC(CN)(CC(O)=O)CC2=C1 MLSOKLXJRHKHGL-UHFFFAOYSA-N 0.000 description 2
- GVNXVHZUNBRSSW-UHFFFAOYSA-N 2-[2-(aminomethyl)-4-hydroxy-1,3-dihydroinden-2-yl]acetic acid Chemical compound C1=CC(O)=C2CC(CN)(CC(O)=O)CC2=C1 GVNXVHZUNBRSSW-UHFFFAOYSA-N 0.000 description 2
- AESOQYXOAGBNOF-UHFFFAOYSA-N 2-[2-(aminomethyl)-4-iodo-1,3-dihydroinden-2-yl]acetic acid Chemical compound C1=CC(I)=C2CC(CN)(CC(O)=O)CC2=C1 AESOQYXOAGBNOF-UHFFFAOYSA-N 0.000 description 2
- KFKKTNSNOHQTQI-UHFFFAOYSA-N 2-[2-(aminomethyl)-4-methoxy-1,3-dihydroinden-2-yl]acetic acid Chemical compound COC1=CC=CC2=C1CC(CN)(CC(O)=O)C2 KFKKTNSNOHQTQI-UHFFFAOYSA-N 0.000 description 2
- PHTBHEKKNNTFCQ-UHFFFAOYSA-N 2-[2-(aminomethyl)-4-methoxycarbonyl-1,3-dihydroinden-2-yl]acetic acid Chemical compound COC(=O)C1=CC=CC2=C1CC(CN)(CC(O)=O)C2 PHTBHEKKNNTFCQ-UHFFFAOYSA-N 0.000 description 2
- JKPDBBJXYQIFBR-UHFFFAOYSA-N 2-[2-(aminomethyl)-4-methyl-1,3-dihydroinden-2-yl]acetic acid Chemical compound CC1=CC=CC2=C1CC(CN)(CC(O)=O)C2 JKPDBBJXYQIFBR-UHFFFAOYSA-N 0.000 description 2
- CEIWUGHYGHQCMY-UHFFFAOYSA-N 2-[2-(aminomethyl)-4-nitro-1,3-dihydroinden-2-yl]acetic acid Chemical compound C1=CC([N+]([O-])=O)=C2CC(CN)(CC(O)=O)CC2=C1 CEIWUGHYGHQCMY-UHFFFAOYSA-N 0.000 description 2
- LVQOLBGEJGXSMK-UHFFFAOYSA-N 2-[2-(aminomethyl)-4-phenyl-1,3-dihydroinden-2-yl]acetic acid Chemical compound C=12CC(CN)(CC(O)=O)CC2=CC=CC=1C1=CC=CC=C1 LVQOLBGEJGXSMK-UHFFFAOYSA-N 0.000 description 2
- OQUGOVRWSBWITN-UHFFFAOYSA-N 2-[2-(aminomethyl)-4-propan-2-yl-1,3-dihydroinden-2-yl]acetic acid Chemical compound CC(C)C1=CC=CC2=C1CC(CN)(CC(O)=O)C2 OQUGOVRWSBWITN-UHFFFAOYSA-N 0.000 description 2
- SQMSWUQMENMMNP-UHFFFAOYSA-N 2-[2-(aminomethyl)-5,6-bis(trifluoromethyl)-1,3-dihydroinden-2-yl]acetic acid Chemical compound FC(F)(F)C1=C(C(F)(F)F)C=C2CC(CN)(CC(O)=O)CC2=C1 SQMSWUQMENMMNP-UHFFFAOYSA-N 0.000 description 2
- ZYPKQKMYWBOENT-UHFFFAOYSA-N 2-[2-(aminomethyl)-5,6-dibromo-1,3-dihydroinden-2-yl]acetic acid Chemical compound BrC1=C(Br)C=C2CC(CN)(CC(O)=O)CC2=C1 ZYPKQKMYWBOENT-UHFFFAOYSA-N 0.000 description 2
- GTDPSHREZDIPGW-UHFFFAOYSA-N 2-[2-(aminomethyl)-5,6-dichloro-1,3-dihydroinden-2-yl]acetic acid Chemical compound ClC1=C(Cl)C=C2CC(CN)(CC(O)=O)CC2=C1 GTDPSHREZDIPGW-UHFFFAOYSA-N 0.000 description 2
- CJRPZSYBVSXRPM-UHFFFAOYSA-N 2-[2-(aminomethyl)-5,6-dimethoxy-1,3-dihydroinden-2-yl]acetic acid Chemical compound C1=C(OC)C(OC)=CC2=C1CC(CN)(CC(O)=O)C2 CJRPZSYBVSXRPM-UHFFFAOYSA-N 0.000 description 2
- UFJVNXKJSFPRSW-UHFFFAOYSA-N 2-[2-(aminomethyl)-5,6-dimethyl-1,3-dihydroinden-2-yl]acetic acid Chemical compound C1=C(C)C(C)=CC2=C1CC(CN)(CC(O)=O)C2 UFJVNXKJSFPRSW-UHFFFAOYSA-N 0.000 description 2
- TZMKPNYEPPXLKG-UHFFFAOYSA-N 2-[2-(aminomethyl)-5,6-diphenyl-1,3-dihydroinden-2-yl]acetic acid Chemical compound C=1C=CC=CC=1C=1C=C2CC(CN)(CC(O)=O)CC2=CC=1C1=CC=CC=C1 TZMKPNYEPPXLKG-UHFFFAOYSA-N 0.000 description 2
- OIWMRNPUPDNZCH-UHFFFAOYSA-N 2-[2-(aminomethyl)-5-(2-methylpropyl)-1,3-dihydroinden-2-yl]acetic acid Chemical compound CC(C)CC1=CC=C2CC(CN)(CC(O)=O)CC2=C1 OIWMRNPUPDNZCH-UHFFFAOYSA-N 0.000 description 2
- WCFSNTNWKDOFDA-UHFFFAOYSA-N 2-[2-(aminomethyl)-5-(dimethylamino)-1,3-dihydroinden-2-yl]acetic acid Chemical compound CN(C)C1=CC=C2CC(CN)(CC(O)=O)CC2=C1 WCFSNTNWKDOFDA-UHFFFAOYSA-N 0.000 description 2
- ZSQAMHGUMHHCNT-UHFFFAOYSA-N 2-[2-(aminomethyl)-5-(methylamino)-1,3-dihydroinden-2-yl]acetic acid Chemical compound CNC1=CC=C2CC(CN)(CC(O)=O)CC2=C1 ZSQAMHGUMHHCNT-UHFFFAOYSA-N 0.000 description 2
- RPFDJYQZQVIZMW-UHFFFAOYSA-N 2-[2-(aminomethyl)-5-(trifluoromethyl)-1,3-dihydroinden-2-yl]acetic acid Chemical compound C1=C(C(F)(F)F)C=C2CC(CN)(CC(O)=O)CC2=C1 RPFDJYQZQVIZMW-UHFFFAOYSA-N 0.000 description 2
- SRFJQVXMHDSZNK-UHFFFAOYSA-N 2-[2-(aminomethyl)-5-bromo-1,3-dihydroinden-2-yl]acetic acid Chemical compound C1=C(Br)C=C2CC(CN)(CC(O)=O)CC2=C1 SRFJQVXMHDSZNK-UHFFFAOYSA-N 0.000 description 2
- ZHRMXRCZZHMQBS-UHFFFAOYSA-N 2-[2-(aminomethyl)-5-chloro-1,3-dihydroinden-2-yl]acetic acid Chemical compound C1=C(Cl)C=C2CC(CN)(CC(O)=O)CC2=C1 ZHRMXRCZZHMQBS-UHFFFAOYSA-N 0.000 description 2
- WWZYNZFKAYHRAR-UHFFFAOYSA-N 2-[2-(aminomethyl)-5-cyano-1,3-dihydroinden-2-yl]acetic acid Chemical compound C1=C(C#N)C=C2CC(CN)(CC(O)=O)CC2=C1 WWZYNZFKAYHRAR-UHFFFAOYSA-N 0.000 description 2
- MOWVRSCJVCQMSE-UHFFFAOYSA-N 2-[2-(aminomethyl)-5-hydroxy-1,3-dihydroinden-2-yl]acetic acid Chemical compound C1=C(O)C=C2CC(CN)(CC(O)=O)CC2=C1 MOWVRSCJVCQMSE-UHFFFAOYSA-N 0.000 description 2
- LANGCJKTGXHZHH-UHFFFAOYSA-N 2-[2-(aminomethyl)-5-iodo-1,3-dihydroinden-2-yl]acetic acid Chemical compound C1=C(I)C=C2CC(CN)(CC(O)=O)CC2=C1 LANGCJKTGXHZHH-UHFFFAOYSA-N 0.000 description 2
- YJLDEDWEXYIOMD-UHFFFAOYSA-N 2-[2-(aminomethyl)-5-methoxy-1,3-dihydroinden-2-yl]acetic acid Chemical compound COC1=CC=C2CC(CN)(CC(O)=O)CC2=C1 YJLDEDWEXYIOMD-UHFFFAOYSA-N 0.000 description 2
- RJBAUYMNKHEERV-UHFFFAOYSA-N 2-[2-(aminomethyl)-5-methoxycarbonyl-1,3-dihydroinden-2-yl]acetic acid Chemical compound COC(=O)C1=CC=C2CC(CN)(CC(O)=O)CC2=C1 RJBAUYMNKHEERV-UHFFFAOYSA-N 0.000 description 2
- SBVLRQZRSHNZRC-UHFFFAOYSA-N 2-[2-(aminomethyl)-5-methyl-1,3-dihydroinden-2-yl]acetic acid Chemical compound CC1=CC=C2CC(CN)(CC(O)=O)CC2=C1 SBVLRQZRSHNZRC-UHFFFAOYSA-N 0.000 description 2
- TVNMFMXAGHQSSI-UHFFFAOYSA-N 2-[2-(aminomethyl)-5-nitro-1,3-dihydroinden-2-yl]acetic acid Chemical compound C1=C([N+]([O-])=O)C=C2CC(CN)(CC(O)=O)CC2=C1 TVNMFMXAGHQSSI-UHFFFAOYSA-N 0.000 description 2
- KAQPTHHXXLYVOD-UHFFFAOYSA-N 2-[2-(aminomethyl)-5-phenyl-1,3-dihydroinden-2-yl]acetic acid Chemical compound C1=C2CC(CN)(CC(O)=O)CC2=CC=C1C1=CC=CC=C1 KAQPTHHXXLYVOD-UHFFFAOYSA-N 0.000 description 2
- HUPXXTVXEPGYBD-UHFFFAOYSA-N 2-[2-(aminomethyl)-5-propan-2-yl-1,3-dihydroinden-2-yl]acetic acid Chemical compound CC(C)C1=CC=C2CC(CN)(CC(O)=O)CC2=C1 HUPXXTVXEPGYBD-UHFFFAOYSA-N 0.000 description 2
- DBRBFIMBDUXPGL-UHFFFAOYSA-N 2-[4-amino-2-(aminomethyl)-1,3-dihydroinden-2-yl]acetic acid Chemical compound C1=CC(N)=C2CC(CN)(CC(O)=O)CC2=C1 DBRBFIMBDUXPGL-UHFFFAOYSA-N 0.000 description 2
- UNMGIOSWSAOLKX-UHFFFAOYSA-N 2-[5-amino-2-(aminomethyl)-1,3-dihydroinden-2-yl]acetic acid Chemical compound C1=C(N)C=C2CC(CN)(CC(O)=O)CC2=C1 UNMGIOSWSAOLKX-UHFFFAOYSA-N 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 230000004770 neurodegeneration Effects 0.000 description 2
- 208000015122 neurodegenerative disease Diseases 0.000 description 2
- 230000002981 neuropathic effect Effects 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 208000021245 head disease Diseases 0.000 description 1
- 230000003483 hypokinetic effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13610099P | 1999-05-26 | 1999-05-26 | |
| US60/136,100 | 1999-05-26 | ||
| PCT/GB2000/001819 WO2000073259A1 (en) | 1999-05-26 | 2000-05-12 | Fused polycyclic amino acids as pharmaceutical agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003500466A JP2003500466A (ja) | 2003-01-07 |
| JP2003500466A5 true JP2003500466A5 (https=) | 2007-07-05 |
Family
ID=22471297
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000621326A Pending JP2003500466A (ja) | 1999-05-26 | 2000-05-12 | 医薬としての融合多環式アミノ酸 |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1180094B1 (https=) |
| JP (1) | JP2003500466A (https=) |
| AT (1) | ATE272048T1 (https=) |
| AU (1) | AU4770400A (https=) |
| BR (1) | BR0010961A (https=) |
| CA (1) | CA2373210A1 (https=) |
| DE (1) | DE60012508T2 (https=) |
| DK (1) | DK1180094T3 (https=) |
| ES (1) | ES2228524T3 (https=) |
| HK (1) | HK1040237B (https=) |
| MX (1) | MXPA01011955A (https=) |
| PT (1) | PT1180094E (https=) |
| WO (1) | WO2000073259A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004016260A1 (en) * | 2002-08-15 | 2004-02-26 | Pfizer Limited | Therapeutic use of fused bicyclic or tricyclic amino acids |
| EP1820502A1 (en) | 2006-02-10 | 2007-08-22 | Laboratorios Del Dr. Esteve, S.A. | Active substance combination comprising azolylcarbinol compounds |
| EP2116539A1 (en) | 2008-04-25 | 2009-11-11 | Laboratorios Del. Dr. Esteve, S.A. | 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof |
| EP2353591A1 (en) | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof |
| EP2353598A1 (en) | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for use in the prevention and/or treatment of postoperative pain |
| EP2388005A1 (en) | 2010-05-21 | 2011-11-23 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy |
| EP2415471A1 (en) | 2010-08-03 | 2012-02-08 | Laboratorios Del. Dr. Esteve, S.A. | Use of sigma ligands in opioid-induced hyperalgesia |
| EP2524694A1 (en) | 2011-05-19 | 2012-11-21 | Laboratorios Del. Dr. Esteve, S.A. | Use of sigma ligands in diabetes type-2 associated pain |
| WO2015091505A1 (en) | 2013-12-17 | 2015-06-25 | Laboratorios Del Dr. Esteve, S.A. | Gabapentinoids and sigma receptor ligands combinations |
| TW201607538A (zh) | 2013-12-17 | 2016-03-01 | 以斯提夫博士實驗室股份有限公司 | 血清素－去甲腎上腺素再攝取抑制劑（ＳＮＲＩＳ）和σ受體配體組合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA44686C2 (uk) * | 1991-11-05 | 2002-03-15 | Смітклайн Бічем Корпорейшн | Похідні індану або індену як антагоністи ендотелінових рецепторів, фармацевтична композиція на їх основі, спосіб їх одержання та спосіб пригнічення ендотелінових рецепторів |
| ATE361909T1 (de) * | 1996-10-23 | 2007-06-15 | Warner Lambert Co | Substituierte gamma-aminobuttersäurederivate als arzneimittel |
| ATE323067T1 (de) * | 1997-10-27 | 2006-04-15 | Warner Lambert Co | Zyklische aminosäuren und deren derivate als arzneimittel |
-
2000
- 2000-05-12 ES ES00929701T patent/ES2228524T3/es not_active Expired - Lifetime
- 2000-05-12 BR BR0010961-4A patent/BR0010961A/pt not_active Application Discontinuation
- 2000-05-12 DK DK00929701T patent/DK1180094T3/da active
- 2000-05-12 CA CA002373210A patent/CA2373210A1/en not_active Abandoned
- 2000-05-12 DE DE60012508T patent/DE60012508T2/de not_active Expired - Fee Related
- 2000-05-12 MX MXPA01011955A patent/MXPA01011955A/es active IP Right Grant
- 2000-05-12 HK HK02101978.2A patent/HK1040237B/en not_active IP Right Cessation
- 2000-05-12 AT AT00929701T patent/ATE272048T1/de not_active IP Right Cessation
- 2000-05-12 EP EP00929701A patent/EP1180094B1/en not_active Expired - Lifetime
- 2000-05-12 JP JP2000621326A patent/JP2003500466A/ja active Pending
- 2000-05-12 PT PT00929701T patent/PT1180094E/pt unknown
- 2000-05-12 WO PCT/GB2000/001819 patent/WO2000073259A1/en not_active Ceased
- 2000-05-12 AU AU47704/00A patent/AU4770400A/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003532731A5 (https=) | ||
| CA2138026A1 (en) | Novel 1,4-dihydroquinoxaline-2,3-diones and uses therefor as glycine receptor antagonists | |
| JP2002527474A5 (ja) | 躁病および双極性障害の治療のための医薬 | |
| JP2004501132A5 (https=) | ||
| RU99112115A (ru) | Энантиомерно чистые основные эфиры арил-циклоалкилгидроксикарбоновых кислот, способ их получения и применение в лекарственных средствах | |
| JP2003500466A5 (https=) | ||
| JP2009526865A5 (https=) | ||
| JP2002518502A5 (https=) | ||
| JP2019530674A5 (https=) | ||
| JP2016537432A5 (https=) | ||
| JP2019512475A (ja) | 治療に有効な量のジカルボン酸化合物を使用した、病気の予防、治療及び治癒 | |
| JP2004522781A5 (https=) | ||
| ES2339021T3 (es) | Derivados de alfa-aminoamida utiles como agentes antiinflamatorios. | |
| JPH1036365A5 (https=) | ||
| KR101156393B1 (ko) | 신경퇴행성 질환 치료를 위한 1-페닐알캐인카복실산 유도체 | |
| RU2013113301A (ru) | Замещенные 2-оксо- и 2-тиоксо-дигидрохинолин-3-карбоксамиды в качестве модуляторов kcnq2/3 | |
| RU99103681A (ru) | Амиды альфа-аминокислот, их получение и терапевтическое применение | |
| JP3112944B2 (ja) | （ｒ）−２−（３−ベンゾイルフェニル）プロピオン酸を含有する鎮痛剤として有用な薬学的組成物 | |
| CN1835910B (zh) | 2-氨基苯甲酰基衍生物 | |
| RU2005136431A (ru) | 4-, 6-или 7-гидроксииндолы с n-оксидными группами и их применение в качестве терапевтических средств | |
| JP2004501888A5 (https=) | ||
| JPH08245658A (ja) | ホスホノ酢酸誘導体および変形性関節疾患を治療するためのその使用 | |
| RU93057732A (ru) | N-//4,5-диокси- и 4,5,8-тригидрокси-9,10-дигидро-9,10-диоксо-2-антраценил(карбонил)-аминокислот, полезные для лечения костносуставных заболеваний | |
| JP2003521500A5 (https=) | ||
| KR960702438A (ko) | 3-(인돌-3-일)프로페노산 유도체 및 N-메틸-D-아스파르테이트 길항제로서의 이의 용도[3-(lndol-3-yl)propenoic acid derivatives and as NMDA antagonists] |